Table 6.
Step | Parameters to be described |
---|---|
EV isolation | |
Cell culture | Cell type Confluency Cellular activation/differentiation status Use of EV-depleted serum (include depletion protocol) or serum-free medium Cell viability Mycoplasma test |
Body fluid | Health/disease status Collection method (disposables, chemicals, procedure) Removal of body fluid specific contaminants Storage |
EV isolation | Differential centrifugation steps Filtration steps Size exclusion chromatography Density gradient Commercially available kits (e.g. chemical, column based) EV quantification method |
EV-RNA characterisation | |
EV-RNA sample preparation | RNase/DNase/proteinase treatment of EV Use of RNA spike RNA isolation method /kit RNA quantification method Bioanalyzer profile of EV-RNA |
Library preparation | Enzymatic treatment to remove phosphates, caps, etc. Method /kit for ligating adapters Pre-amplification steps Size selection steps Bioanalyzer profile of library |
Sequencing | Platform Maximum read length Direction (paired or single end) Number of cycles Number of replicates (biological or technical) |
Bioinformatics | Pre-processing software (trimming/clipping, cut-off values) Reference genome assemblies (release numbers) Primary analysis software (alignment and mapping criteria) Browsers and annotation tools Normalisation methods and software Statistical methods and tools for differential expression analysis |
Validation | Validation technique Normalisation procedure; validation of reference genes |
Deposition in database | Name of database |
EV-RNA functional analysis | |
EV-RNA transfer | Target cell type and activation/differentiation status Methodology (EV-RNA labelling, target cell RT-qPCR) Quantity of EV per target cell |
EV-RNA function | Methodology (transcriptome analysis, functional read-out) Endogenous expression levels of EV-RNA in target cell Proof to attribute functional effects to the RNA component of EV |